Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.

Kiyoaki UryuYoshinori ImamuraRai ShimoyamaTakahiro MaseYoshiaki FujimuraMaki HayashiMegu OhtakiKeiko OtaniMakoto HibinoShigeto HoriuchiTomoya FukuiRyuta FukaiYusuke ChiharaAkihiko IwaseNoriko YamadaYukihiro TamuraHiromasa HaradaNobuaki ShinozakiToyoshi ShimadaAsuka TsuyaMasahiro FukuokaHironobu Minami

Published in: Cancer chemotherapy and pharmacology (2024)

In addition to the first-generation EGFR-TKIs, the second- and third-generation EGFR-TKIs also resulted in OS deterioration in patients with EGFR mutation-positive NSCLC when used concurrently with pH-regulating drugs.

Keyphrases

epidermal growth factor receptor
advanced non small cell lung cancer
tyrosine kinase
small cell lung cancer
quality improvement
big data
machine learning
brain metastases
data analysis
chronic myeloid leukemia